PARIS, May 16, 2011 /PRNewswire/ -- InspireMD, Inc. (OTCBB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, will partake in the EuroPCR conference this week. MGuard, and the recently launched MGuard Prime, InspireMD's new Cobalt Chromium mesh protective stent system will be on display at booth #P14. Both products feature InspireMD's MicroNet® Mesh Technology, a potentially superior solution for thrombus management in heart attack patients. MGuard Prime is CE Marked and indicated for Primary PCI for STEMI, Saphenous Vein Grafts and ACS with visible thrombus.
InspireMD's cocktail reception and scientific symposium will take place Wednesday, May 18th at 6:30 p.m. adjacent to the EuroPCR conference at the Concorde Lafayette Hotel, Paris, Grande Etoile D'Or Hall. The symposium will be chaired by Dr. Martin Leon and the meeting faculty includes Drs. Alexandre Abizaid, Antonio Colombo, Dariusz Dudek, Eberhard Grube, Chaim Lotan, Sigmund Silber and more. The session, titled, "Thrombus Management in STEMI: MGuard and the MASTER Trial," will reveal recent clinical data of MGuard in STEMI patients as well as important insights into the MGuard MicroNet® Mesh Technology and presentations and discussion of recent challenging MGuard PPCI cases.
Also on Wednesday, May 18, at 8 a.m., Dr. Anthopoulos will present "Single-centre experience using MGuard stent platform in primary PCI in STEMI" at the session of Primary PCI in STEMI patients: new techniques Session comprising selected EuroPCR 2011 abstract submissions in room 243.
On Thursday, May 19th at 1 p.m., Dr. Esteves will present: "Comparative analysis of a distal protection system and the new stent M-Guard for the treatment of complex lesions in saphenous vein grafts" as part of the session: DES / protection devices in saphenous vein graft PCI in room 353 Technique.
Finally, don't miss the InspireMD Boo
Copyright©2010 PR Newswire.
All rights reserved